OVID – Ovid Therapeutics Inc.
Ovid Therapeutics Inc.OVID
$1.31Name : Ovid Therapeutics Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $93,288,176.00
EPSttm : -0.54
Ovid Therapeutics Inc.
$1.31
0.39%$0.005Float Short %
5.82
Margin Of Safety %
Put/Call OI Ratio
0.56
EPS Next Q Diff
EPS Last/This Y
-0.07
EPS This/Next Y
0.08
Price
1.3
Target Price
4.15
Analyst Recom
1
Performance Q
39.9
Relative Volume
0.39
Beta
0.11
Ticker: OVID
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | OVID | 1.65 | 0.16 | 11.81 | 15391 |
| 2025-10-21 | OVID | 1.595 | 0.60 | 11.06 | 21839 |
| 2025-10-22 | OVID | 1.6 | 0.60 | 0.11 | 21886 |
| 2025-10-23 | OVID | 1.55 | 0.60 | 0.06 | 21829 |
| 2025-10-24 | OVID | 1.635 | 0.59 | 0.00 | 22080 |
| 2025-10-27 | OVID | 1.6 | 0.59 | 0.00 | 22081 |
| 2025-10-28 | OVID | 1.495 | 0.59 | 0.08 | 22179 |
| 2025-10-29 | OVID | 1.45 | 0.58 | 0.21 | 22268 |
| 2025-10-30 | OVID | 1.36 | 0.58 | 0.04 | 22346 |
| 2025-10-31 | OVID | 1.4 | 0.58 | 0.14 | 22411 |
| 2025-11-03 | OVID | 1.385 | 0.58 | 0.04 | 22435 |
| 2025-11-04 | OVID | 1.32 | 0.58 | 0.16 | 22441 |
| 2025-11-05 | OVID | 1.33 | 0.58 | 0.05 | 22392 |
| 2025-11-06 | OVID | 1.33 | 0.58 | 0.01 | 22377 |
| 2025-11-07 | OVID | 1.32 | 0.58 | 0.00 | 22475 |
| 2025-11-10 | OVID | 1.355 | 0.58 | 0.11 | 22490 |
| 2025-11-11 | OVID | 1.355 | 0.57 | 7.50 | 22579 |
| 2025-11-12 | OVID | 1.33 | 0.57 | 0.01 | 22527 |
| 2025-11-13 | OVID | 1.2 | 0.57 | 0.02 | 22560 |
| 2025-11-14 | OVID | 1.31 | 0.56 | 0.00 | 22617 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | OVID | 1.65 | 26.0 | - | -0.44 |
| 2025-10-21 | OVID | 1.59 | 26.0 | - | -0.44 |
| 2025-10-22 | OVID | 1.61 | 26.0 | - | -0.44 |
| 2025-10-23 | OVID | 1.56 | 26.0 | - | -0.44 |
| 2025-10-24 | OVID | 1.64 | 26.0 | - | -0.44 |
| 2025-10-27 | OVID | 1.60 | 26.0 | - | -0.44 |
| 2025-10-28 | OVID | 1.49 | 26.0 | - | -0.44 |
| 2025-10-29 | OVID | 1.45 | 26.0 | - | -0.44 |
| 2025-10-30 | OVID | 1.37 | 26.0 | - | -0.44 |
| 2025-10-31 | OVID | 1.39 | 26.0 | - | -0.44 |
| 2025-11-03 | OVID | 1.38 | 26.0 | - | -0.44 |
| 2025-11-04 | OVID | 1.33 | 26.0 | - | -0.44 |
| 2025-11-05 | OVID | 1.33 | 26.0 | - | -0.44 |
| 2025-11-06 | OVID | 1.33 | 26.0 | - | -0.44 |
| 2025-11-07 | OVID | 1.32 | 26.0 | - | -0.44 |
| 2025-11-10 | OVID | 1.35 | 26.0 | - | -0.44 |
| 2025-11-11 | OVID | 1.35 | 26.0 | - | -0.44 |
| 2025-11-12 | OVID | 1.32 | 26.0 | - | -0.44 |
| 2025-11-13 | OVID | 1.21 | 26.0 | - | -0.44 |
| 2025-11-14 | OVID | 1.30 | 26.0 | - | -0.44 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | OVID | 0.00 | -18.56 | 1.14 |
| 2025-10-21 | OVID | 0.00 | -18.56 | 1.14 |
| 2025-10-22 | OVID | 0.00 | -18.56 | 1.14 |
| 2025-10-23 | OVID | 0.00 | -18.56 | 1.14 |
| 2025-10-24 | OVID | 0.00 | -18.56 | 1.14 |
| 2025-10-27 | OVID | 0.00 | -18.96 | 6.44 |
| 2025-10-28 | OVID | 0.00 | -18.96 | 6.44 |
| 2025-10-29 | OVID | 0.00 | -18.96 | 6.44 |
| 2025-10-30 | OVID | 0.00 | -18.96 | 6.44 |
| 2025-10-31 | OVID | 0.00 | -18.96 | 6.44 |
| 2025-11-03 | OVID | 0.00 | -18.77 | 6.44 |
| 2025-11-04 | OVID | 0.00 | -18.77 | 6.44 |
| 2025-11-05 | OVID | 0.00 | -18.77 | 6.44 |
| 2025-11-06 | OVID | 0.00 | -18.77 | 6.44 |
| 2025-11-07 | OVID | 0.00 | -18.77 | 6.44 |
| 2025-11-10 | OVID | 0.00 | -19.45 | 6.44 |
| 2025-11-11 | OVID | 0.00 | -19.45 | 6.44 |
| 2025-11-12 | OVID | 0.00 | -19.45 | 5.82 |
| 2025-11-13 | OVID | 0.00 | -19.45 | 5.82 |
| 2025-11-14 | OVID | 0.00 | -19.45 | 5.82 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.14
Avg. EPS Est. Next Quarter
-0.09
Insider Transactions
Institutional Transactions
-19.45
Beta
0.11
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
14
Growth Score
35
Sentiment Score
35
Actual DrawDown %
81.3
Max Drawdown 5-Year %
-96.3
Target Price
4.15
P/E
Forward P/E
PEG
P/S
14.06
P/B
2.08
P/Free Cash Flow
EPS
-0.51
Average EPS Est. Cur. Y
-0.44
EPS Next Y. (Est.)
-0.36
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-549.62
Relative Volume
0.39
Return on Equity vs Sector %
-95.3
Return on Equity vs Industry %
-80.5
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
Ovid Therapeutics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 23
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It develops OV350 IV, OV4071, and OV4041, an oral program that behave similarly in phenotypical screens for the treatment of psychosis in people with NSD and LBD; and OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
stock quote shares OVID – Ovid Therapeutics Inc. Stock Price stock today
news today OVID – Ovid Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OVID – Ovid Therapeutics Inc. yahoo finance google finance
stock history OVID – Ovid Therapeutics Inc. invest stock market
stock prices OVID premarket after hours
ticker OVID fair value insiders trading